(Q36043283)

11 August 2017

1 reference

title

Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome). (English)

1 reference

toxic epidermal necrolysis

11 August 2017

1 reference

Philippe Paquet

1

1 reference

PubMed ID

15713983

11 August 2017

Gérald E Piérard

series ordinal

2

1 reference

PubMed ID

15713983

11 August 2017

Pascale Quatresooz

series ordinal

3

1 reference

11 August 2017

15 February 2005

1 reference

International Archives of Allergy and Immunology

11 August 2017

1 reference

11 August 2017

136

1 reference

11 August 2017

3

1 reference

11 August 2017

205-216

1 reference

The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification

11 August 2017

1 reference

Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme

21 January 2018

1 reference

The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).

21 January 2018

1 reference

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

21 January 2018

1 reference

Direct and metabolism-dependent toxicity of sulphasalazine and its principal metabolites towards human erythrocytes and leucocytes

21 January 2018

1 reference

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.

21 January 2018

1 reference

Covalent binding of carbamazepine reactive metabolites to P450 isoforms present in the skin.

21 January 2018

1 reference

A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.

21 January 2018

1 reference

Drug metabolism in the skin

21 January 2018

1 reference

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

21 January 2018

1 reference

Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand

21 January 2018

1 reference

Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity

21 January 2018

1 reference

21 January 2018

Apoptosis: an overview

1 reference

Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome

21 January 2018

1 reference

Anthralin stimulates keratinocyte-derived proinflammatory cytokines via generation of reactive oxygen species

21 January 2018

1 reference

Involvement of oxidative stress in apoptosis induced by a mixture of isothiazolinones in normal human keratinocytes

21 January 2018

1 reference

Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative beta-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability

21 January 2018

1 reference

Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis

21 January 2018

1 reference

Reduction in tumor necrosis factor receptor affinity and cytotoxicity by glucocorticoids

21 January 2018

1 reference

Inhibition by glucocorticoids of tumor necrosis factor-mediated cytotoxicity. Evidence against lipocortin involvement.

21 January 2018

1 reference

Effect of dexamethasone, 6-mercaptopurine and cyclosporine A on intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 expression

21 January 2018

1 reference

Inflammatory skin diseases, T cells, and immune surveillance

21 January 2018

1 reference

Treatment of toxic epidermal necrolysis and a review of six cases

21 January 2018

1 reference

Toxic epidermal necrolysis in a burns centre: a 6-year review

21 January 2018

1 reference

Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin

21 January 2018

1 reference

Toxic epidermal necrolysis treated with intravenous high-dose immunoglobulins: our experience

21 January 2018

1 reference

Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children

21 January 2018

1 reference

Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression

21 January 2018

1 reference

Toxic epidermal necrolysis treated with N-acetylcysteine

21 January 2018

1 reference

Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway

21 January 2018

1 reference

Thalidomide in dermatology. New indications for an old drug

21 January 2018

1 reference

Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use.

21 January 2018

1 reference

Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production

21 January 2018

1 reference

Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis.

21 January 2018

1 reference

Intravenous ulinastatin therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis in pediatric patients. Three case reports

21 January 2018

1 reference

Plasmapheresis in toxic epidermal necrolysis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000083947

1 reference

11 August 2017

1 reference

PubMed ID

15713983